News

Evotec AG and Almirall announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics through a novel approach to disrupt cell…
Read More...

Avista Pharma Solutions has announced upgrades to its Agawam, MA facility, increasing its analytical chemistry footprint while expanding its compendial and raw material testing…
Read More...

Halozyme Therapeutics announced that Roche has received approval from Health Canada for a subcutaneous (SC) formulation of trastuzumab (Herceptin SC) for the treatment of patients with…
Read More...

Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation for North American rights to Samumed's SM04646, being developed for the treatment of…
Read More...

CRISPR Therapeutics and ViaCyte announced a collaboration focused on the discovery, development, and commercialization of gene-edited allogeneic stem cell therapies for the treatment of…
Read More...

LEO Pharma A/S and MorphoSys AG announced an expansion of their existing strategic alliance to include peptide-derived therapeutics. The objective of the alliance is to identify novel,…
Read More...

Allergan plc announced it has agreed to acquire Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting…
Read More...

Sanofi will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets.…
Read More...

PMI BioPharma Solutions officially formed in January of 2018, has established complete research and manufacturing operations at multiple sites located in both Nashville and Celina…
Read More...

Recipharm has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub. The connection, which was…
Read More...

Paragon BioTeck, a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies,…
Read More...

Boehringer Ingelheim announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies.…
Read More...

Consort Medical plc announces a significant new contract with Opiant Pharmaceuticals. Opiant is a specialty pharmaceutical company developing pharmacological treatments for addictions…
Read More...

EpimAb Biotherapeutics announced that it has filed an IND for its most advanced therapeutic development candidate EMB01. The applications were simultaneously submitted to the U.S. Food…
Read More...

Cambrex Corporation announced it has completed the acquisition of Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO) located in…
Read More...

Pall Corporation has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company. The companies will…
Read More...

Casma Therapeutics announced a research collaboration with Fondazione Telethon, founder of the Telethon Institute of Genetics and Medicine (TIGEM), to develop new therapies for…
Read More...

Sherpa Clinical Packaging (Sherpa) has announced an agreement to be acquired by PCI Pharma Services (PCI). Sherpa, headquartered in San Diego, CA, provides clinical trial material…
Read More...

Portola Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Company’s Prior Approval Supplement (PAS) filing for the…
Read More...

WuXi Biologics and Inhibrx announced that the companies have entered into an exclusive partnership for the GMP manufacturing of certain of Inhibrx's protein-based therapeutics. The…
Read More...